Claudia Andreetta Selected Research

Drug Therapy (Chemotherapy)

2/2024	Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.
8/2023	Is It Time to Reassess the Role of Radiotherapy Treatment in Ovarian Cancer?
1/2023	Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
1/2022	Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?
1/2021	Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial.
3/2012	Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy.
11/2010	First-line chemotherapy with or without biologic agents for metastatic breast cancer.
7/2009	Determinants of recovery from amenorrhea in premenopausal breast cancer patients receiving adjuvant chemotherapy in the taxane era.
7/2008	Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer.
3/2008	Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Andreetta Research Topics

Disease

11	Breast Neoplasms (Breast Cancer) 03/2024 - 06/2007
9	Neoplasms (Cancer) 03/2024 - 11/2006
5	Ovarian Neoplasms (Ovarian Cancer) 02/2024 - 01/2022
2	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 01/2023
2	Neoplasm Metastasis (Metastasis) 11/2020 - 04/2018
1	Carcinoma (Carcinomatosis) 02/2024
1	Fallopian Tube Neoplasms 02/2024
1	Drug-Related Side Effects and Adverse Reactions 02/2024
1	Genomic Instability 01/2024
1	Disease Progression 01/2023
1	Lymphadenopathy 01/2022
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022
1	Extramammary Paget Disease (Paget Disease, Extramammary) 11/2020
1	Amenorrhea 07/2009
1	Cardiotoxicity 03/2008
1	Stomatitis 03/2008

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 03/2024 - 07/2008
3	PlatinumIBA 02/2024 - 01/2022
3	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 07/2008
2	Carboplatin (JM8)FDA LinkGeneric 02/2024 - 01/2023
2	liposomal doxorubicin (Doxil)FDA Link 02/2024 - 03/2008
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2024 - 02/2023
2	Hormones (Hormone)IBA 01/2021 - 06/2007
2	taxaneIBA 07/2009 - 09/2007
2	Taxoids (Taxanes)IBA 07/2009 - 09/2007
2	AnthracyclinesIBA 03/2008 - 09/2007
1	AlpelisibIBA 03/2024
1	TrabectedinIBA 02/2024
1	Gemcitabine FDA Link 02/2024
1	Topotecan (Hycamtin)FDA LinkGeneric 02/2024
1	avelumabIBA 01/2023
1	SurvivinIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Trastuzumab (Herceptin)FDA Link 11/2020
1	Cisplatin (Platino)FDA LinkGeneric 11/2020
1	Epidermal Growth Factor (EGF)IBA 11/2020
1	Biological FactorsIBA 03/2012
1	Epirubicin (Ellence)FDA LinkGeneric 07/2008
1	Gefitinib (Iressa)FDA Link 07/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2008
1	1-dodecylpyridoxal (PLD)IBA 03/2008
1	Thymidine PhosphorylaseIBA 09/2007
1	Estrogen ReceptorsIBA 07/2007
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2007
1	Plasminogen Activator Inhibitor 1IBA 07/2007
1	Plasminogen InactivatorsIBA 07/2007
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2007
1	Aromatase InhibitorsIBA 06/2007
1	Tamoxifen FDA LinkGeneric 06/2007

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 02/2024 - 09/2007
9	Therapeutics 01/2024 - 11/2006
1	Radiotherapy 08/2023
1	Hysterectomy 03/2023
1	Ovariectomy (Oophorectomy) 03/2023
1	Minimally Invasive Surgical Procedures 01/2023
1	Immunotherapy 01/2023
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 01/2022
1	Biological Therapy 11/2010
1	Adjuvant Chemotherapy 07/2009
1	Aftercare (After-Treatment) 09/2007